Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Talks to Applied Clinical Trials About How FDA Cuts Are Creating New Bottlenecks in Clinical Operations

In Part 2 of the interview; Ron Lanton, partner, Lanton Law, talks FDA layoffs and their impact on inspections and clinical trial timelines. The interview can be seen here.

clinical research, clinical trials, FDA, healthcare, HHSRon LantonJune 7, 2025Clinical trials, FDA, R&D, inspections, supply chain
0 Likes
Previous

Rising API Tariffs Are Forcing Pharma to Shift R&D Resources

FDA, healthcare, life sciences, pharmaceuticals, PhRMARon LantonJune 16, 2025pharmaceutical tariffs, tariffs, active pharmaceutical ingredients, R&D, FDA, Clinical trials
Next

Lanton Law Talks to Applied Clinical Trials About The Hidden Impact of Drug Pricing on Government Clinical Trials

clinical research, clinical trials, HHS, healthcareRon LantonJune 7, 2025Clinical trials, drug prices, rebates, HHS, government sponsored clinical trials